首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current oncology reports

缩写:CURR ONCOL REP

ISSN:1523-3790

e-ISSN:1534-6269

IF/分区:5.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1925
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yoann Birling,Deep Jyoti Bhuyan,Fan Feng et al. Yoann Birling et al.
Intro: Mind-body therapies (MBTs) are promising forms of treatment for depression and anxiety symptoms in people with cancer, however, their effectiveness has not been compared. The objective of this study is to rank the ...
Chin Hang Yiu,Kevin Winardi,Christine Y Lu Chin Hang Yiu
Purpose of review: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, producing durable responses across multiple malignancies. However, treatment outcomes may be influenced by immunological drug-drug in...
Yuan You Yang,Lu Xie,Xin Sun et al. Yuan You Yang et al.
Purpose of review: This review aims to synthesize and critically appraise the most impactful advances in radiotherapy (RT) for soft tissue sarcomas (STSs) reported in 2025, with a focus on technological innovations, fract...
Jeremy Y Ng,Aimun Qadeer Shah,Lana Abu Narr et al. Jeremy Y Ng et al.
Purpose of review: The increasing use of complementary, alternative, and integrative medicine (CAIM) among patients with cancer raises questions about physicians' knowledge and counseling practices in this area. This qual...
Atul Kumar Gupta Atul Kumar Gupta
Purpose of review: Malignant fungating wounds (MFWs) represent a profoundly distressing complication of advanced cancer, affecting an estimated 5-10% of patients with solid tumors and imposing a disproportionate burden on...
Patrick Y Muller,Johannes Eisinger,Pakeeza Sayyed et al. Patrick Y Muller et al.
Purpose of review: Most novel anti-cancer therapies involve combining multiple immuno-oncology and/or targeted drugs. The historical paradigm of exploring combination regimens only after approval of the individual drugs i...